Will Third Time Be Charm For Lovenox Patent Re-issuance? Aventis Considers Options

Aventis will continue to pursue re-issuance of its '618 Lovenox patent despite a second rejection letter from the Patent & Trademark Office. The firm has not decided whether to appeal the decision or present further evidence.